These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Structure of methionine γ-lyase from Clostridium sporogenes. Revtovich S; Anufrieva N; Morozova E; Kulikova V; Nikulin A; Demidkina T Acta Crystallogr F Struct Biol Commun; 2016 Jan; 72(Pt 1):65-71. PubMed ID: 26750487 [TBL] [Abstract][Full Text] [Related]
6. Conjugates of methionine γ-lyase with polysialic acid: Two approaches to antitumor therapy. Morozova E; Anufrieva N; Koval V; Lesnova E; Kushch A; Timofeeva V; Solovieva A; Kulikova V; Revtovich S; Demidkina T Int J Biol Macromol; 2021 Jul; 182():394-401. PubMed ID: 33839182 [TBL] [Abstract][Full Text] [Related]
7. Methionine tumor starvation by erythrocyte-encapsulated methionine gamma-lyase activity controlled with per os vitamin B6. Gay F; Aguera K; Sénéchal K; Tainturier A; Berlier W; Maucort-Boulch D; Honnorat J; Horand F; Godfrin Y; Bourgeaux V Cancer Med; 2017 Jun; 6(6):1437-1452. PubMed ID: 28544589 [TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-loaded polysaccharide nanoparticles suppress the growth of murine colorectal carcinoma and inhibit the metastasis of murine mammary carcinoma in rodent models. Li M; Tang Z; Zhang D; Sun H; Liu H; Zhang Y; Zhang Y; Chen X Biomaterials; 2015 May; 51():161-172. PubMed ID: 25771007 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis. Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316 [TBL] [Abstract][Full Text] [Related]
11. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials. Sun B; Deng C; Meng F; Zhang J; Zhong Z Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338 [TBL] [Abstract][Full Text] [Related]
12. A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo. Tarasenko N; Cutts SM; Phillips DR; Berkovitch-Luria G; Bardugo-Nissim E; Weitman M; Nudelman A; Rephaeli A Biochem Pharmacol; 2014 Mar; 88(2):158-68. PubMed ID: 24463168 [TBL] [Abstract][Full Text] [Related]
13. Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy. Yang Y; Lu X; Liu Q; Dai Y; Zhu X; Wen Y; Xu J; Lu Y; Zhao D; Chen X; Li N Eur J Pharm Sci; 2017 Jul; 105():219-229. PubMed ID: 28526602 [TBL] [Abstract][Full Text] [Related]
14. Engineered breast tumor targeting peptide ligand modified liposomal doxorubicin and the effect of peptide density on anticancer activity. Shahin M; Soudy R; Aliabadi HM; Kneteman N; Kaur K; Lavasanifar A Biomaterials; 2013 May; 34(16):4089-4097. PubMed ID: 23465829 [TBL] [Abstract][Full Text] [Related]
15. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy. Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784 [TBL] [Abstract][Full Text] [Related]
16. Oral Recombinant Methioninase Combined with Caffeine and Doxorubicin Induced Regression of a Doxorubicin-resistant Synovial Sarcoma in a PDOX Mouse Model. Higuchi T; Kawaguchi K; Miyake K; Han Q; Tan Y; Oshiro H; Sugisawa N; Zhang Z; Razmjooei S; Yamamoto N; Hayashi K; Kimura H; Miwa S; Igarashi K; Chawla SP; Singh AS; Eilber FC; Singh SR; Tsuchiya H; Hoffman RM Anticancer Res; 2018 Oct; 38(10):5639-5644. PubMed ID: 30275182 [TBL] [Abstract][Full Text] [Related]
18. Methods to Study the Role of Methionine-Restricted Diet and Methioninase in Cancer Growth Control. Chaturvedi S; Bertino JR Methods Mol Biol; 2019; 1866():1-12. PubMed ID: 30725403 [TBL] [Abstract][Full Text] [Related]